124 related articles for article (PubMed ID: 12386829)
21. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
[TBL] [Abstract][Full Text] [Related]
22. [Adenovirus-mediated transfer of the herpes simplex virus thymidine rinase gene used by several methods].
Huang T; Gao G; Chen S
Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):625-7. PubMed ID: 12417082
[TBL] [Abstract][Full Text] [Related]
23. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
Gao Ding Cheng ; An W; Dai J
Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
[TBL] [Abstract][Full Text] [Related]
24. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
25. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
Hall SJ; Mutchnik SE; Yang G; Timme TL; Nasu Y; Bangma CH; Woo SL; Shaker M; Thompson TC
Cancer Gene Ther; 1999; 6(1):54-63. PubMed ID: 10078964
[TBL] [Abstract][Full Text] [Related]
26. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
[TBL] [Abstract][Full Text] [Related]
27. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
Xie Y; Gilbert JD; Kim JH; Freytag SO
Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
[TBL] [Abstract][Full Text] [Related]
30. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
[TBL] [Abstract][Full Text] [Related]
31. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
Zhao Y; Zhang X; Hui H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
[TBL] [Abstract][Full Text] [Related]
32. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
Rautsi O; Lehmusvaara S; Ketola A; Määttä AM; Wahlfors J; Pellinen R
Cancer Gene Ther; 2008 May; 15(5):303-14. PubMed ID: 18309353
[TBL] [Abstract][Full Text] [Related]
33. Suppression of bladder cancer growth by adeno-associated virus vector-mediated combination of HSV-TK and endostatin in vitro.
Pan JG; Luo RQ; Zhou X; Han RF; Zeng GW
Clin Lab; 2013; 59(9-10):1077-89. PubMed ID: 24273931
[TBL] [Abstract][Full Text] [Related]
34. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
35. [Combined interleukin-2 and herpes simplex virus thymidine kinase gene therapy for head and neck squamous cell carcinoma].
Liu S; Liang C; Yang H; Xian J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):426-9. PubMed ID: 12761956
[TBL] [Abstract][Full Text] [Related]
36. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.
O'Malley BW; Chen SH; Schwartz MR; Woo SL
Cancer Res; 1995 Mar; 55(5):1080-5. PubMed ID: 7866992
[TBL] [Abstract][Full Text] [Related]
38. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity and antiangiogenesis by fibroblast growth factor 2-targeted Ad-TK cancer gene therapy.
Saito K; Khan K; Sosnowski B; Li D; O'Malley BW
Laryngoscope; 2009 Apr; 119(4):665-74. PubMed ID: 19213040
[TBL] [Abstract][Full Text] [Related]
40. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
Hall SJ; Sanford MA; Atkinson G; Chen SH
Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]